Anti-cancer drug kills 124 in Japan

Anti-cancer drug kills 124 in Japan

Side effects from the cancer-fighting drug Gefitinib have resulted in 124 deaths in Japan, a government official said today.

The dead were among 494 patients who have developed debilitating lung disorders, including pneumonia, blamed on the drug, according to Toshihito Ikeda of the Health and Welfare Ministry.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited